Global News

Parexel adds three programs to Parexel Academy

Friday, April 10, 2015 01:47 PM

Parexel International, a global biopharmaceutical services provider, has announced three new academic programs at the Parexel Academy. The offerings span the globe and are designed to prepare students for careers in the biopharmaceutical industry. They include:

More... »

Quest Diagnostics

BioXcel, Takeda partner to repurpose assets for orphan diseases

Friday, April 10, 2015 01:45 PM

BioXcel, a Branford, Conn.-based provider of cloud-based pharma big data solutions for discovering novel products, has partnered with Takeda Development Center Americas for the repurposing of assets across the gamut of rare diseases.

More... »

NIH funds nine antimicrobial resistance diagnostics projects

Friday, April 10, 2015 01:31 PM

The National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH, has awarded more than $11 million in first-year funding for nine research projects supporting enhanced diagnostics to rapidly detect antimicrobial-resistant bacteria. The awardee institutions will develop tools to identify certain pathogens that frequently cause infections in health care settings and, specifically, those that are resistant to most antimicrobials. Advancing the development of rapid and innovative diagnostic tests for identifying and characterizing resistant bacteria is a key goal of the President’s recent National Action Plan for Combating Antibiotic-Resistant Bacteria.

More... »

Pfizer launches competitive grants program for cardiovascular disease research

Friday, April 10, 2015 01:21 PM

Pfizer has launched a new competitive grants program to support research projects investigating the role of Proprotein Convertase Subtilisin Kexin type 9 (PCSK9) in health and cardiovascular disease. This competitive grants program, which is an extension of the Advancing Science through Pfizer Investigator Research Exchange (ASPIRE) Cardiovascular program, is part of Pfizer's ongoing commitment to translate scientific discoveries into innovative medicines for patients with cardiovascular disease.

More... »

Eisai to restructure U.S. operations, cut workforce 25%

Friday, April 10, 2015 01:19 PM

Eisai Inc., a U.S. subsidiary of Eisai Co., a global R&D-based pharmaceutical company headquartered in Japan, plans to restructure its operations in the U.S., including a reduction of its workforce by approximately 25% across various U.S. functions. This realignment supports Eisai's desire to create a more efficient and focused organization.

More... »

Relmada Therapeutics appoints Lisa Nolan SVP of business development

Friday, April 10, 2015 11:54 AM

Relmada Therapeutics, a clinical-stage company developing novel therapies for the treatment of chronic pain, has appointed Lisa Nolan, Ph.D., as senior vice president of business development. Nolan will be responsible for overseeing alliance and business development activities across the company.

More... »

Margaret A. Hamburg appointed Institute of Medicine foreign secretary

Friday, April 10, 2015 11:29 AM

Margaret A. Hamburg, former commissioner of the FDA, has been appointed as the next foreign secretary of the Institute of Medicine, the health arm of the National Academy of Sciences. In this part-time position, Hamburg will work as a senior adviser on international matters to the IOM president and council and as liaison to foreign academies of medicine and science.

More... »

EnteroMedics appoints Scott A. Shikora EVP of medical affairs, CMO

Thursday, April 9, 2015 02:09 PM

EnteroMedics, a developer of medical devices using neuroblocking therapy to treat obesity, metabolic diseases and other gastrointestinal disorders, has named Scott A. Shikora, M.D., FACS, executive vice president of medical affairs and chief medical officer of EnteroMedics, effective June 1. He will lead the company's medical affairs, clinical and regulatory functions.

More... »

Greenphire opens new global headquarters

Thursday, April 9, 2015 01:49 PM

Greenphire, a provider of payment technology for the clinical trials industry, has moved its operations to new headquarters in King of Prussia, Pa. The move quadruples the company's office space in the region and supports Greenphire's ongoing growth strategy that will see the business rapidly scale its operational infrastructure to support its growing global client base.

More... »

Sanford-Burnham, Daiichi Sankyo ink agreement

Thursday, April 9, 2015 01:48 PM

Sanford-Burnham Medical Research Institute, a nonprofit, independent institute that employs more than 1,000 scientists and staff in San Diego, Calif., and Orlando, Fla., has signed a licensing agreement to further develop a first-in-class small molecule with Daiichi Sankyo for the treatment of cardiovascular-metabolic disease.

More... »



April 20

Christie Clinic, PMG Research's 12th clinical research site, expands its geographic reach north to Illinois

Clinipace acquires Accovion to expand European presence, following an infusion of equity that could lead to more deals

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs